1-2 of 2
Keywords: Sarcopenia
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Low Skeletal Muscle Mass Predicts Relevant Outcomes in Palliative Urological Oncology: A Systematic Review and Meta-Analysis

Open Access
Subject Area:
Karger e-Journal Backfile Collection 2023 , Further Areas
Hans-Jonas Meyer, Andreas Wienke, Marina Zamsheva, Alexey Surov
Journal: Urologia Internationalis
Urol Int (2023) 107 (3): 219–229.
https://doi.org/10.1159/000527277
Published Online: 22 March 2023
..., (2) LSMM/sarcopenia defined by cross-sectional imaging, and (3) reported odds ratio or hazard ratio with confidence interval (CI). Exclusion criteria were (1) systematic reviews, (2) case reports, (3) non-English language, and (4) sarcopenia/LSMM identified on other modalities than CT and or MRI...
View article titled, Low Skeletal Muscle Mass Predicts Relevant Outcomes in Palliative Urological Oncology: A Systematic Review and Meta-Analysis
Open the PDF for Low Skeletal Muscle Mass Predicts Relevant Outcomes in Palliative Urological Oncology: A Systematic Review and Meta-Analysis in another window
Journal Articles

Sarcopenia as a Predictive Factor for Response to Upfront Cisplatin-Based Chemotherapy in Patients with Muscle-Invasive Urothelial Bladder Cancer

Available to Purchase
Subject Area:
Further Areas
Judith Stangl-Kremser, Andrea Mari, David D’Andrea, Shoji Kimura, Irene Resch, Shahrokh F. Shariat, Tobias Klatte
Journal: Urologia Internationalis
Urol Int (2018) 101 (2): 197–200.
https://doi.org/10.1159/000489013
Published Online: 08 August 2018
...Judith Stangl-Kremser; Andrea Mari; David D’Andrea; Shoji Kimura; Irene Resch; Shahrokh F. Shariat; Tobias Klatte Purpose: We hypothesized sarcopenia as predictive factor as a response to upfront chemotherapy of muscle-invasive urothelial bladder cancer (MIBC). Methods: We retrospectively studied...
View article titled, Sarcopenia as a Predictive Factor for Response to Upfront Cisplatin-Based Chemotherapy in Patients with Muscle-Invasive Urothelial Bladder Cancer
Open the PDF for Sarcopenia as a Predictive Factor for Response to Upfront Cisplatin-Based Chemotherapy in Patients with Muscle-Invasive Urothelial Bladder Cancer in another window